Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling
- PMID: 11781608
- DOI: 10.1038/sj.bmt.1703271
Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling
Abstract
In this paper, we address methods of multivariate regression. We discuss the value of regression compared to matched pairs analysis, methods of coding variables, basic concepts of the Cox model and interpretation of results of the Cox model. We present methods of handling variables whose effect changes with time. We present methods to check the assumptions of the Cox regression. Finally, and perhaps most importantly, we provide suggestions for presenting the results in clear and thorough tables and graphs.
Similar articles
-
Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis.Bone Marrow Transplant. 2001 Nov;28(10):909-15. doi: 10.1038/sj.bmt.1703260. Bone Marrow Transplant. 2001. PMID: 11753543 Review.
-
Statistical evaluation of bone marrow transplantation data.Arch Immunol Ther Exp (Warsz). 1995;43(2):107-10. Arch Immunol Ther Exp (Warsz). 1995. PMID: 8744724
-
Psychosocial influences on 305 adults' survival after bone marrow transplantation; depression, smoking, and behavioral self-regulation.J Psychosom Res. 2004 Aug;57(2):145-54. doi: 10.1016/S0022-3999(03)00599-3. J Psychosom Res. 2004. PMID: 15465068
-
Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study.Melanoma Res. 2006 Oct;16(5):429-33. doi: 10.1097/01.cmr.0000222602.80803.e1. Melanoma Res. 2006. PMID: 17013092
-
Regression analysis.Pract Neurol. 2007 Aug;7(4):259-64. doi: 10.1136/jnnp.2007.120055. Pract Neurol. 2007. PMID: 17636142 Review. No abstract available.
Cited by
-
TCRαβ/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders.Blood Adv. 2022 Jan 11;6(1):281-292. doi: 10.1182/bloodadvances.2021005628. Blood Adv. 2022. PMID: 34592755 Free PMC article.
-
Class II HLA mismatch improves outcomes following haploidentical transplantation with posttransplant cyclophosphamide.Blood Adv. 2020 Oct 27;4(20):5311-5321. doi: 10.1182/bloodadvances.2020003110. Blood Adv. 2020. PMID: 33108457 Free PMC article.
-
Application of the Multiplicative-Additive Model in the Bone Marrow Transplantation Survival Data Including Competing Risks.Iran J Public Health. 2015 Apr;44(4):543-50. Iran J Public Health. 2015. PMID: 26056673 Free PMC article.
-
One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing.Biol Blood Marrow Transplant. 2011 May;17(5):640-8. doi: 10.1016/j.bbmt.2010.07.022. Epub 2010 Jul 30. Biol Blood Marrow Transplant. 2011. PMID: 20674756 Free PMC article.
-
B-cell activating factor (BAFF) plasma level at the time of chronic GvHD diagnosis is a potential predictor of non-relapse mortality.Bone Marrow Transplant. 2017 Jul;52(7):1010-1015. doi: 10.1038/bmt.2017.73. Epub 2017 May 8. Bone Marrow Transplant. 2017. PMID: 28481353 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical